JP2014526246A5 - - Google Patents

Download PDF

Info

Publication number
JP2014526246A5
JP2014526246A5 JP2014529633A JP2014529633A JP2014526246A5 JP 2014526246 A5 JP2014526246 A5 JP 2014526246A5 JP 2014529633 A JP2014529633 A JP 2014529633A JP 2014529633 A JP2014529633 A JP 2014529633A JP 2014526246 A5 JP2014526246 A5 JP 2014526246A5
Authority
JP
Japan
Prior art keywords
filter
sample
virus
population
parvovirus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014529633A
Other languages
English (en)
Japanese (ja)
Other versions
JP6198278B2 (ja
JP2014526246A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NL2012/050619 external-priority patent/WO2013036118A1/en
Publication of JP2014526246A publication Critical patent/JP2014526246A/ja
Publication of JP2014526246A5 publication Critical patent/JP2014526246A5/ja
Application granted granted Critical
Publication of JP6198278B2 publication Critical patent/JP6198278B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014529633A 2011-09-08 2012-09-07 Aav調製物からの混入ウイルスの除去 Expired - Fee Related JP6198278B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161532176P 2011-09-08 2011-09-08
US61/532,176 2011-09-08
EP11180594.1 2011-09-08
EP11180594 2011-09-08
PCT/NL2012/050619 WO2013036118A1 (en) 2011-09-08 2012-09-07 Removal of contaminating viruses from aav preparations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017125458A Division JP6624690B2 (ja) 2011-09-08 2017-06-27 Aav調製物からの混入ウイルスの除去

Publications (3)

Publication Number Publication Date
JP2014526246A JP2014526246A (ja) 2014-10-06
JP2014526246A5 true JP2014526246A5 (enExample) 2015-10-01
JP6198278B2 JP6198278B2 (ja) 2017-09-20

Family

ID=47832422

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014529633A Expired - Fee Related JP6198278B2 (ja) 2011-09-08 2012-09-07 Aav調製物からの混入ウイルスの除去
JP2017125458A Expired - Fee Related JP6624690B2 (ja) 2011-09-08 2017-06-27 Aav調製物からの混入ウイルスの除去

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017125458A Expired - Fee Related JP6624690B2 (ja) 2011-09-08 2017-06-27 Aav調製物からの混入ウイルスの除去

Country Status (19)

Country Link
US (3) US9840694B2 (enExample)
EP (3) EP3425044A1 (enExample)
JP (2) JP6198278B2 (enExample)
KR (1) KR101961347B1 (enExample)
CN (2) CN103857790B (enExample)
AU (1) AU2012304993B2 (enExample)
BR (1) BR112014005255A2 (enExample)
CA (1) CA2847604A1 (enExample)
DK (1) DK2744895T3 (enExample)
EA (1) EA027511B1 (enExample)
ES (1) ES2558168T3 (enExample)
HU (1) HUE026579T2 (enExample)
IL (1) IL231398A (enExample)
MX (1) MX349601B (enExample)
PL (1) PL2744895T3 (enExample)
PT (1) PT2744895E (enExample)
SI (1) SI2744895T1 (enExample)
WO (1) WO2013036118A1 (enExample)
ZA (1) ZA201401714B (enExample)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012304993B2 (en) * 2011-09-08 2017-09-14 Uniqure Ip B.V. Removal of contaminating viruses from AAV preparations
WO2015060722A1 (en) 2013-10-24 2015-04-30 Uniqure Ip B.V. Aav-5 pseudotyped vector for gene therapy for neurological diseases
US10577627B2 (en) 2014-06-09 2020-03-03 Voyager Therapeutics, Inc. Chimeric capsids
CN107106689A (zh) 2014-11-05 2017-08-29 沃雅戈治疗公司 用于治疗帕金森病的aadc多核苷酸
IL292999A (en) 2014-11-14 2022-07-01 Voyager Therapeutics Inc Compositions and methods of treating amyotrophic lateral sclerosis (als)
CN112410338A (zh) 2014-11-14 2021-02-26 沃雅戈治疗公司 调节性多核苷酸
BR112017011217A2 (pt) * 2014-11-28 2018-02-06 Uniqure Ip B.V. impurezas de dna em uma composição compreendendo um vírion parvoviral
WO2016094783A1 (en) 2014-12-12 2016-06-16 Voyager Therapeutics, Inc. Compositions and methods for the production of scaav
EP3237618B1 (en) 2014-12-24 2019-05-22 uniQure IP B.V. Rnai induced huntingtin gene suppression
EP3054007A1 (en) 2015-02-09 2016-08-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
US11326182B2 (en) 2016-04-29 2022-05-10 Voyager Therapeutics, Inc. Compositions for the treatment of disease
WO2017189964A2 (en) 2016-04-29 2017-11-02 Voyager Therapeutics, Inc. Compositions for the treatment of disease
SG11201809699XA (en) 2016-05-18 2018-12-28 Voyager Therapeutics Inc Modulatory polynucleotides
KR20220108216A (ko) 2016-05-18 2022-08-02 보이저 테라퓨틱스, 인크. 헌팅톤 질환을 치료하기 위한 조성물 및 방법
CN110650673B (zh) 2016-08-30 2024-04-09 加利福尼亚大学董事会 用于生物医学靶向和递送的方法以及用于实践该方法的装置和系统
SG11201909870SA (en) 2017-05-05 2019-11-28 Voyager Therapeutics Inc Compositions and methods of treating amyotrophic lateral sclerosis (als)
JP2020518259A (ja) 2017-05-05 2020-06-25 ボイジャー セラピューティクス インコーポレイテッドVoyager Therapeutics,Inc. ハンチントン病治療組成物および方法
JOP20190269A1 (ar) 2017-06-15 2019-11-20 Voyager Therapeutics Inc بولي نوكليوتيدات aadc لعلاج مرض باركنسون
JP7229989B2 (ja) 2017-07-17 2023-02-28 ボイジャー セラピューティクス インコーポレイテッド 軌道アレイガイドシステム
MX2020003042A (es) 2017-09-29 2020-11-18 Voyager Therapeutics Inc Rescate del fenotipo neurológico central y periférico de la ataxia de friedreich mediante administración intravenosa.
EP4454654A3 (en) 2017-10-16 2025-02-19 Voyager Therapeutics, Inc. Treatment of amyotrophic lateral sclerosis (als)
US11434502B2 (en) 2017-10-16 2022-09-06 Voyager Therapeutics, Inc. Treatment of amyotrophic lateral sclerosis (ALS)
RS64499B1 (sr) 2018-01-17 2023-09-29 Meiragtx Uk Ii Ltd Modifikovani protein kapsida raav za gensku terapiju
EP3794126A1 (en) 2018-05-15 2021-03-24 Voyager Therapeutics, Inc. Compositions and methods for the treatment of parkinson's disease
EP3850098A1 (en) 2018-09-12 2021-07-21 uniQure IP B.V. Rnai induced c9orf72 suppression for the treatment of als/ftd
CN113383010B (zh) 2018-09-28 2025-09-09 沃雅戈治疗公司 具有经工程化改造的启动子的共济蛋白表达构建体及其使用方法
US20210324483A1 (en) * 2018-10-15 2021-10-21 Regenxbio Inc. Method for measuring the infectivity of replication defective viral vectors and viruses
WO2020104435A1 (en) 2018-11-19 2020-05-28 Uniqure Ip B.V. A companion diagnostic to monitor the effects of gene therapy
WO2020104480A1 (en) 2018-11-19 2020-05-28 Uniqure Biopharma B.V. Adeno-associated virus vectors for expressing fviii mimetics and uses thereof
US20200199625A1 (en) 2018-11-19 2020-06-25 Uniqure Ip B.V. RNAi induced reduction of ataxin-3 for the treatment of Spinocerebellar ataxia type 3
EP3883582A1 (en) 2018-11-19 2021-09-29 uniQure IP B.V. Method and means to deliver mirna to target cells
MX2021008542A (es) * 2019-01-18 2021-11-12 Voyager Therapeutics Inc Métodos y sistemas para la producción de partículas de aav.
TW202045529A (zh) 2019-02-15 2020-12-16 美商聖加莫治療股份有限公司 用於生產重組aav之組合物及方法
WO2020219897A1 (en) * 2019-04-24 2020-10-29 Biogen Ma Inc. Methods for production of recombinant adeno-associated viruses
KR20220081971A (ko) 2019-07-15 2022-06-16 메이라지티엑스 유케이 Ii 리미티드 관절염 질환 치료용 변형된 aav 캡시드 단백질
WO2021053018A1 (en) 2019-09-16 2021-03-25 Uniqure Ip B.V. Targeting misspliced transcripts in genetic disorders
US20230020565A1 (en) 2019-12-04 2023-01-19 Sangamo Therapeutics, Inc. Novel compositions and methods for producing recombinant aav
JP7737374B2 (ja) * 2019-12-12 2025-09-10 イー・エム・デイー・ミリポア・コーポレイシヨン 透析濾過緩衝液を用いて増強したウイルス濾過
EP4097239A2 (en) * 2020-01-29 2022-12-07 Voyager Therapeutics, Inc. Methods and systems for producing aav particles
US20230103302A1 (en) * 2020-02-28 2023-04-06 Asahi Kasei Medical Co., Ltd. Method for evaluating viral clearance capability
CA3174872A1 (en) 2020-04-07 2021-10-14 Sander Jan Hendrik Van Deventer Gene constructs for silencing angiopoietin-like 3 (angptl3) and uses thereof
CN115427561B (zh) 2021-03-09 2024-06-04 辉大(上海)生物科技有限公司 工程化CRISPR/Cas13系统及其用途
JP2024515027A (ja) * 2021-03-30 2024-04-04 スリーエム イノベイティブ プロパティズ カンパニー 中空糸膜及びその作製方法
CN117120152A (zh) * 2021-03-30 2023-11-24 3M创新有限公司 包含聚砜和聚噁唑啉的中空纤维膜及其制造方法
WO2022214635A1 (en) 2021-04-08 2022-10-13 Stichting Vu Nucleic acid molecules for compensation of stxbp1 haploinsufficiency and their use in the treatment of stxbp1-related disorders
AU2022285138A1 (en) 2021-06-02 2023-11-30 Uniqure Biopharma B.V. Adeno-associated virus vectors modified to bind high-density lipoprotein
WO2022268811A1 (en) 2021-06-21 2022-12-29 Uniqure Biopharma B.V. Improved lysis procedures
US20250382611A1 (en) 2021-06-21 2025-12-18 Uniqure Biopharma B.V. Gene constructs for silencing alpha-synuclein and uses thereof
WO2023283962A1 (en) 2021-07-16 2023-01-19 Huigene Therapeutics Co., Ltd. Modified aav capsid for gene therapy and methods thereof
CN119032174A (zh) 2022-04-12 2024-11-26 优尼科生物制药有限公司 ApoE的核酸调节
WO2023198702A1 (en) 2022-04-12 2023-10-19 Uniqure Biopharma B.V. Nucleic acid regulation of c9orf72
US20250230437A1 (en) 2022-04-12 2025-07-17 Uniqure Biopharma B.V. Novel systems for nucleic acid regulation
JP2025512061A (ja) 2022-04-12 2025-04-16 ユニキュアー バイオファーマ ビー.ブイ. Sncaの核酸調節
US20240209324A1 (en) * 2022-12-22 2024-06-27 Cytiva Us Llc Virus separation
CN121358754A (zh) 2023-04-18 2026-01-16 优尼科生物制药有限公司 具有外周器官去靶向性的新型嗜神经性腺相关病毒衣壳
AU2024256392A1 (en) 2023-04-18 2025-10-23 Uniqure Biopharma B.V. Gene delivery vehicles comprising rna and antibodies
EP4731267A1 (en) 2023-06-23 2026-04-29 uniQure biopharma B.V. Novel fragile x constructs
WO2025051805A1 (en) 2023-09-04 2025-03-13 Uniqure Biopharma B.V. Novel neurotropic recombinant adeno-associated virus particles
AU2024357870A1 (en) 2023-10-11 2026-04-23 Uniqure Biopharma B.V. Further novel systems for nucleic acid regulation
AU2024360616A1 (en) 2023-10-11 2026-04-23 Uniqure Biopharma B.V. Novel nucleic acid regulation of huntingtin gene
AU2024358914A1 (en) 2023-10-11 2026-04-23 Uniqure Biopharma B.V. Nucleic acid regulation of msh3 in repeat expansion disorders
WO2025114524A1 (en) 2023-11-30 2025-06-05 Uniqure Biopharma B.V. Formulations for viral drug products
WO2025219443A1 (en) 2024-04-19 2025-10-23 Uniqure Biopharma B.V. Nucleic acid for a1at regulation
WO2026041788A1 (en) 2024-08-22 2026-02-26 Uniqure Biopharma B.V Novel bbb interacting capsids
US20260125704A1 (en) 2024-08-22 2026-05-07 Uniqure Biopharma B.V. rAAV capsids
WO2026087074A1 (en) 2024-10-21 2026-04-30 Invision 20/20 Bardet-biedl syndrome 10 (bbs10) protein gene therapy

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
AU4270196A (en) 1994-10-07 1996-05-02 Lutz Gissmann Papilloma virus-like particles, fusion proteins and process for producing the same
DE19709186C2 (de) * 1997-03-06 1999-10-14 Medigene Ag Filtrationsverfahren zur Trennung von Viren
US6103526A (en) 1998-10-08 2000-08-15 Protein Sciences Corporation Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using
ATE454445T1 (de) 1998-11-10 2010-01-15 Univ North Carolina Virusvektoren und verfahren für ihre herstellung und verabreichung.
US6593123B1 (en) * 2000-08-07 2003-07-15 Avigen, Inc. Large-scale recombinant adeno-associated virus (rAAV) production and purification
US6723551B2 (en) 2001-11-09 2004-04-20 The United States Of America As Represented By The Department Of Health And Human Services Production of adeno-associated virus in insect cells
WO2003074714A1 (en) 2002-03-05 2003-09-12 Stichting Voor De Technische Wetenschappen Baculovirus expression system
US20050009168A1 (en) * 2003-05-12 2005-01-13 Robbins Joan Marie Methods and apparatus for Adeno associated virus purification
ES2785223T3 (es) * 2006-06-21 2020-10-06 Uniqure Ip Bv Células de insecto para la producción de vectores de AAV
WO2008109721A1 (en) * 2007-03-06 2008-09-12 Introgen Therapeutics, Inc. Chromatographic methods for assessing adenovirus purity
US20100323429A1 (en) * 2008-04-10 2010-12-23 Yu-Chen Hu Methods for purifying baculovirus
KR101812813B1 (ko) * 2009-06-16 2017-12-27 젠자임 코포레이션 재조합 aav 벡터에 대한 개선된 정제 방법
ES2680915T3 (es) * 2010-01-28 2018-09-11 The Children's Hospital Of Philadelphia Plataforma de fabricación escalable para la purificación de vectores virales y vectores virales purificados de este modo para su utilización en terapia génica
AU2012304993B2 (en) 2011-09-08 2017-09-14 Uniqure Ip B.V. Removal of contaminating viruses from AAV preparations

Similar Documents

Publication Publication Date Title
JP6956824B2 (ja) 生体高分子ユニットおよびウイルスを液体から分離するための方法
WO2012025943A4 (en) Method for purifying water by contacting water with a porous rice husk ash and clay mixture and apparatus therefor
Ge et al. High-performance zeolite NaA membranes on polymer− zeolite composite hollow fiber supports
JP2006515227A5 (enExample)
JP6522001B2 (ja) 中空糸濾過膜
JP2019217501A (ja) 増強された汚れ保持容量を有するフィルタ構造
JP2009125071A (ja) 膜イオン交換クロマトグラフィーのための媒体
JP2010227757A (ja) 複合分離膜
US20030201229A1 (en) Process for prefiltration of a protein solution
JP2023502995A (ja) 改善された尿素捕捉のための吸着剤粒子を含む多孔質膜
US20190054397A1 (en) Protein purification device
CN112892229A (zh) 一种病毒复合过滤膜及其制备方法
CN206463797U (zh) 一种具有多种功能的简化净水工艺的膜元件
KR101599112B1 (ko) 항바이러스 여재용 양전하 코팅제, 항바이러스 여재 및 이의 제조방법
JP6444615B2 (ja) 分離容器およびウイルスの濃縮・精製方法
CN202400913U (zh) 一种净水滤芯及净水器
EP1624950B1 (en) Process for prefiltration of a protein solution
CN206121528U (zh) 一种抗菌除病毒、吸附重金属离子的中空纤维膜复合滤芯
KR101466249B1 (ko) 제습-정수 장치
JP5516835B2 (ja) 多段積多層平膜
DE102011082830A1 (de) Membran zur Gasseparation und Verfahren zum Herstellen eines Filtermoduls zur Gasseparation
WO2020051215A1 (en) Tangential flow filters having extractables adsorber
JP2011092801A (ja) 浄水フィルタ及び該浄水フィルタを備えた浄水器
CN208732751U (zh) 一种复合滤芯和净水器
CN207025094U (zh) 一种复合纳滤膜